Enlivex Therapeutics Statistics

Total Valuation

TLV:ENLV has a market cap or net worth of ILS 88.36 million. The enterprise value is 5.07 million.

Market Cap	88.36M
Enterprise Value	5.07M

Important Dates

The next estimated earnings date is Friday, June 13, 2025.

Earnings Date	Jun 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+10.44%
Shares Change (QoQ)	+5.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	17.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.03
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.11

Financial Position

The company has a current ratio of 6.84, with a Debt / Equity ratio of 0.02.

Current Ratio	6.84
Quick Ratio	6.56
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -55.95% and return on invested capital (ROIC) is -35.16%.

Return on Equity (ROE)	-55.95%
Return on Assets (ROA)	-30.10%
Return on Invested Capital (ROIC)	-35.16%
Return on Capital Employed (ROCE)	-65.04%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.52% in the last 52 weeks. The beta is 0.85, so TLV:ENLV's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-34.52%
50-Day Moving Average	374.25
200-Day Moving Average	441.95
Relative Strength Index (RSI)	56.08
Average Volume (20 Days)	23,561

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.75

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-56.59M
Pretax Income	-54.69M
Net Income	-54.69M
EBITDA	-54.60M
EBIT	-56.59M
Earnings Per Share (EPS)	-2.67

Full Income Statement

Balance Sheet

The company has 85.58 million in cash and 1.94 million in debt, giving a net cash position of 83.63 million.

Cash & Cash Equivalents	85.58M
Total Debt	1.94M
Net Cash	83.63M
Net Cash Per Share	n/a
Equity (Book Value)	85.92M
Book Value Per Share	3.63
Working Capital	80.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -47.38 million and capital expenditures -375,157, giving a free cash flow of -47.75 million.

Operating Cash Flow	-47.38M
Capital Expenditures	-375,157
Free Cash Flow	-47.75M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TLV:ENLV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.44%
Shareholder Yield	-10.44%
Earnings Yield	-61.89%
FCF Yield	-54.05%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a